NASDAQ: ITCI

Company Deals

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B

Fineline Cube Jan 15, 2025

US-based Johnson & Johnson (J&J, NYSE: JNJ) is set to acquire all outstanding shares of...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod